Patents by Inventor Daniel W. Goodman

Daniel W. Goodman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Forceps with linear trigger kickout mechanism
    Patent number: 11944369
    Abstract: A forceps includes shaft members each having a jaw member disposed at a distal end thereof and configured move the jaw members between open and closed position. A knife deployment mechanism includes a trigger moveable along a longitudinal axis to deploy a knife between retracted and extended positions between the jaw members, the knife deployment mechanism including links that cooperate to actuate the knife. A knife kickout mechanism is pivotably coupled to one link and is configured to engage a ramp disposed in a shaft member upon approximation of the shaft members, the knife kickout is configured to cooperate with the links to urge the knife back to an at rest position upon the opening of the shaft members.
    Type: Grant
    Filed: March 31, 2023
    Date of Patent: April 2, 2024
    Assignee: Covidien LP
    Inventors: Jennifer L. Rich, Craig V. Krastins, Daniel W. Mercier, Kelley D. Goodman, Grant T. Sims
  • Treatment for Attention-Deficit Hyperactivity Disorder
    Publication number: 20120070494
    Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity, using eltoprazine and related compounds is provided.
    Type: Application
    Filed: August 16, 2011
    Publication date: March 22, 2012
    Applicant: Psychogenics, Inc.
    Inventors: Daniela Brunner, Daniel W. Goodman
  • Treatment for Attention-Deficit Hyperactivity Disorder
    Publication number: 20110008425
    Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity, using eltoprazine and related compounds is provided.
    Type: Application
    Filed: September 20, 2010
    Publication date: January 13, 2011
    Applicant: Psychogenics, Inc.
    Inventors: Daniela Brunner, Daniel W. Goodman
  • Analogues of lipid mediators derived from ?-3 PUFAs and methods of use
    Patent number: 7595341
    Abstract: The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 ?-3; EPA], but with a longer tissue half-life and enhanced bioactivity. These analogues may be used to treat inflammatory, angioproliferative, cardiovascular, thrombophlebotic, vascular, ocular, dermatologic, neurodegenerative, pulmonary, endocrine, reproductive, rheumatologic and gastrointestinal diseases.
    Type: Grant
    Filed: April 30, 2008
    Date of Patent: September 29, 2009
    Assignees: Resolvyx Pharmacuticals, Inc., The Brigham and Women's Hospital
    Inventors: Daniel W. Goodman, Michael R. Hanley, Stuart L. Bursten, Charles N. Serhan
  • Treatment for attention-deficit hyperactivity disorder
    Patent number: 7557109
    Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity, using eltoprazine and related compounds is provided.
    Type: Grant
    Filed: September 2, 2005
    Date of Patent: July 7, 2009
    Assignee: Psychogenics, Inc.
    Inventors: Daniela Brunner, Daniel W. Goodman
  • Treatment for Attention-Deficit Hyperactivity Disorder
    Publication number: 20090104261
    Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity, using eltoprazine and related compounds is provided.
    Type: Application
    Filed: December 24, 2008
    Publication date: April 23, 2009
    Applicant: Psychogenics, Inc.
    Inventors: Daniela Brunner, Daniel W. Goodman
  • Treatment for attention-deficit hyperactivity disorder
    Patent number: 7504395
    Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity, using eltoprazine and related compounds is provided.
    Type: Grant
    Filed: July 19, 2002
    Date of Patent: March 17, 2009
    Assignee: Psychogenics, Inc.
    Inventors: Daniela Brunner, Daniel W. Goodman
  • Analogues of lipid mediators derived from omega-3 PUFAs and methods of use
    Publication number: 20080207753
    Abstract: The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 ?-3; EPA], but with a longer tissue half-life and enhanced bioactivity. These analogues may be used to treat inflammatory, angioproliferative, cardiovascular, thrombophlebotic, vascular, ocular, dermatologic, neurodegenerative, pulmonary, endocrine, reproductive, rheumatologic and gastrointestinal diseases.
    Type: Application
    Filed: April 30, 2008
    Publication date: August 28, 2008
    Applicants: Resolvyx Pharmaceuticals, Inc., The Brigham and Women's Hospital, Inc.
    Inventors: Daniel W. Goodman, Michael R. Hanley, Stuart L. Bursten, Charles N. Serhan
  • Analogues of lipid mediators derived from omega-3 PUFAs and methods of use
    Patent number: 7378444
    Abstract: The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 ?-3; EPA], but with a longer tissue half-life and enhanced bioactivity. These analogues may be used to treat inflammatory, angioproliferative, cardiovascular, thrombophlebotic, vascular, ocular, dermatologic, neurodegenerative, pulmonary, endocrine, reproductive, rheumatologic and gastrointestinal diseases.
    Type: Grant
    Filed: June 13, 2003
    Date of Patent: May 27, 2008
    Assignees: Brigham and Women's Hospital, Inc., Resolvyx Pharmaceuticals, Inc.
    Inventors: Daniel W. Goodman, Michael R. Hanley, Stuart L. Bursten, Charles N. Serhan
  • Analogues of lipid mediators derived from omega-3 PUFAs and methods of use
    Publication number: 20040044050
    Abstract: The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 &ohgr;-3; EPA], but with a longer tissue half-life and enhanced bioactivity. These analogues may be used to treat inflammatory, angioproliferative, cardiovascular, thrombophlebotic, vascular, ocular, dermatologic, neurodegenerative, pulmonary, endocrine, reproductive, rheumatologic and gastrointestinal diseases.
    Type: Application
    Filed: June 13, 2003
    Publication date: March 4, 2004
    Inventors: Daniel W. Goodman, Michael R. Hanley, Stuart L. Bursten
  • Treatment for attention-deficit hyperactivity disorder
    Publication number: 20030050308
    Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity, using eltoprazine and related compounds is provided.
    Type: Application
    Filed: July 19, 2002
    Publication date: March 13, 2003
    Inventors: Daniela Brunner, Daniel W. Goodman